STOCK TITAN

2seventy bio to Participate in 43rd Annual TD Cowen Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

2seventy bio, Inc. (NASDAQ: TSVT) will present at the 43rd Annual TD Cowen Health Care Conference on March 7, 2023, at 10:30 AM ET in Boston, MA. The management team will discuss the company's innovative approaches to immuno-oncology and cellular therapies aimed at treating various cancer types. A live webcast of the presentation will be available on the company's website, with a replay accessible for 30 days afterward. 2seventy bio is focused on developing groundbreaking therapies to disrupt the cancer treatment landscape through rapid and genuine innovation.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- 2seventy bio, Inc. (Nasdaq: TSVT) announced today that members of the management team will present at the 43rd Annual TD Cowen Health Care Conference at the Boston Marriott Copley Place in Boston, MA on March 7, 2023 at 10:30am ET.

A live webcast will be available via the Investors and Media section of 2seventy bio’s website at https://ir.2seventybio.com/. A replay will be archived on 2seventy bio’s site for 30 days following the event.

About 2seventy bio

Our name, 2seventy bio, reflects why we do what we do - TIME. Cancer rips time away, and our goal is to work at the maximum speed of translating human thought into action – 270 miles per hour – to give the people we serve more time. We are building the leading immuno-oncology cell therapy company, focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape.

With a deep understanding of the human body’s immune response to tumor cells and how to translate cell therapies into practice, we’re applying this knowledge to deliver next generation cellular therapies that focus on a broad range of hematologic malignancies, including the first FDA-approved CAR T cell therapy for multiple myeloma, as well as solid tumors. Our research and development is focused on delivering therapies that are designed with the goal to “think” smarter and faster than the disease. Importantly, we remain focused on accomplishing these goals by staying genuine and authentic to our “why” and keeping our people and culture top of mind every day.

For more information, visit www.2seventybio.com.

Follow 2seventy bio on social media: Twitter and LinkedIn.

2seventy bio is a trademark of 2seventy bio, Inc.

Investors:

Elizabeth Pingpank, 860-463-0469

elizabeth.pingpank@2seventybio.com

Media:

Morgan Adams, 774-313-9852

morgan.adams@2seventybio.com

Source: 2seventy bio, Inc.

FAQ

When is 2seventy bio's presentation at the TD Cowen Health Care Conference?

2seventy bio will present at the TD Cowen Health Care Conference on March 7, 2023, at 10:30 AM ET.

Where will the TD Cowen Health Care Conference be held?

The conference will take place at the Boston Marriott Copley Place in Boston, MA.

How can I watch the 2seventy bio presentation online?

The presentation will be available via live webcast on 2seventy bio’s website, with a replay for 30 days afterward.

What is 2seventy bio's focus in cancer treatment?

2seventy bio is focused on developing next-generation immuno-oncology therapies targeting a range of hematologic malignancies and solid tumors.

What is the ticker symbol for 2seventy bio?

The ticker symbol for 2seventy bio is TSVT.

2seventy bio, Inc.

NASDAQ:TSVT

TSVT Rankings

TSVT Latest News

TSVT Stock Data

155.75M
49.50M
4.05%
90.75%
9.88%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
CAMBRIDGE